Esplenomegalia gigante por síndrome de Felty

  • Estela Torres de Taboada Hospital Nacional, Itauguá
  • Dora Montiel-Jarolín Hospital Nacional, Itauguá
  • Marta Sanguina Hospital Nacional, Itauguá
  • Edgar López Hospital Nacional, Itauguá
Palabras clave: artritis reumatoide, síndrome de Felty, esplenomegalia

Resumen

Se presenta caso de mujer de 56 años de edad que consulta por esplenomegalia gigante y severa bicitopenia, secundaria a artritis reumatoide. El cuadro hematológico revirtió tras esplenectomía.

Biografía del autor

Estela Torres de Taboada, Hospital Nacional, Itauguá

Jefa de Sala del  Servicio de Clínica Médica. Dpto. de Medicina Interna

Dora Montiel-Jarolín, Hospital Nacional, Itauguá

Servicio de Clínica Médica. Departamento de Medicina Interna.

Marta Sanguina, Hospital Nacional, Itauguá

Servicio de Clínica Médica. Departamento de Medicina Interna.

Edgar López, Hospital Nacional, Itauguá

Médico Residente del Dpto. de Medicina Interna.

Citas

Firestein GS, Budd RC, Gabriel SE, McInnes IB, O'Dell JR. Kelley's Textbook of Rheumatology, 6th Edition. Elsevier Ed. Chapter 67, Pag 1023-1026

Felty AR. Chronic arthritis in the adult associates with splenomegaly and leukopenia. Bull Johns Hopkins Hosp 1924; 35:16

Campion G, Maddison PJ, Goulding N, James I, Ahern MJ, Watt I, Sansom D. The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations. Medicine (Baltimore). 1990 Mar; 69(2): 69-80.

Burks EJ, Loughran TP Jr. Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome. Blood Rev. 2006 Sep; 20(5): 245-66.

Sibley JT, Haga M, Visram DA, Mitchell DM. The clinical course of Felty's syndrome compared to matched controls. J Rheumatol. 1991 Aug; 18(8): 1163-7.

Bartels CM, Bell CL, Shinki K, Rosenthal A, Bridges AJ. Changing trends in serious extra-articular manifestations of rheumatoid arthritis among United State veterans over 20 years. Rheumatology (Oxford). 2010 Sep; 49(9): 1670-5.

Campion G, Maddison PJ, Goulding N, James I, Ahern MJ, Watt I, Sansom D. The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations. Medicine (Baltimore). 1990 Mar; 69(2): 69-80.

Breedveld FC, Fibbe WE, Hermans J, van der Meer JW, Cats A. Factors influencing the incidence of infections in Felty's syndrome. Arch Intern Med. 1987 May; 147(5): 915-20.

Thorne C, Urowitz MB. Long-term outcome in Felty's syndrome. Ann Rheum Dis. 1982 Oct; 41(5): 486-9.

Wassenberg S, Herborn G, Rau R. Methotrexate treatment in Felty's syndrome. Br J Rheumatol. 1998 Aug; 37(8): 908-11.

Hellmich B, Schnabel A, Gross WL. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor. Semin Arthritis Rheum. 1999 Oct; 29(2): 82-99.

Rashba EJ, Rowe JM, Packman CH. Treatment of the neutropenia of Felty syndrome. Blood Rev. 1996 Sep;10(3):177-84.

Stanworth SJ, Bhavnani M, Chattopadhya C, Miller H, Swinson DR. Treatment of Felty's syndrome with the haemopoietic growth factor granulocyte colony-stimulating factor (G-CSF). QJM. 1998 Jan; 91(1): 49-56.

Fiechtner JJ, Miller DR, Starkebaum G. Reversal of neutropenia with methotrexate treatment in patients with Felty's syndrome. Correlation of response with neutrophil-reactive IgG. Arthritis Rheum. 1989 Feb; 32(2): 194-201.

Laszlo J, Jones R, Silberman HR, Banks PM. Splenectomy for Felty's syndrome. Clinicopathological study of 27 patients. Arch Intern Med. 1978 Apr; 138(4): 597-602.

Leguizamón S, María Angélica. Editorial: A 101 años del primer caso de leishmaniosis visceral en las Américas. Mem Inst Invest Cienc Salud 2012; 8(1): 3-4.

Canese J. Gran incremento de leishmaniasis visceral humana en Paraguay. Pediatr. (Asunción) 2010; 37(3): 167-168

Publicado
2014-03-01
Sección
REPORTES DE CASOS